NCT05961852

Brief Summary

To evaluate the preliminary efficacy of combination of cutting and drug-coated balloon for the treatment of resistant AVF stenosis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
19

participants targeted

Target at P25-P50 for phase_1

Timeline
Completed

Started Aug 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 15, 2018

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2019

Completed
4 years until next milestone

First Submitted

Initial submission to the registry

July 17, 2023

Completed
10 days until next milestone

First Posted

Study publicly available on registry

July 27, 2023

Completed
Last Updated

July 27, 2023

Status Verified

July 1, 2023

Enrollment Period

11 months

First QC Date

July 17, 2023

Last Update Submit

July 17, 2023

Conditions

Keywords

arteriovenous fistuladrug-coated ballooncutting balloonstenosis

Outcome Measures

Primary Outcomes (1)

  • Target lesion primary patency

    Time from index treatment to repeat treatment of target lesion or thrombosis of circuit.

    6 months after index procedure

Study Arms (1)

Treatment arm

EXPERIMENTAL

Cutting and drug-coated balloon angioplasty

Device: Angioplasty

Interventions

Angioplasty with cutting and drug-coated balloon

Treatment arm

Eligibility Criteria

Age21 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Failing mature upper limb AVF
  • Resistant stenosis (\>30% residual stenosis) after optimal conventional balloon angioplasty (appropriately sized balloon, inflated up to rated burst pressure, at least twice for at least a minute per inflation)
  • Patient is \>= 21 years of age
  • Ability to provide informed consent

You may not qualify if:

  • Thrombosed AVF
  • Target lesion has a sharp angle (\> 45 degrees)
  • Lesions requiring cutting balloon size \> 7 mm
  • Coagulopathy or thrombocytopaenia that cannot be adequately managed for the procedure
  • Contraindication to dual antiplatelet therapy
  • Severe allergy to contrast media that cannot be adequately managed for the procedure
  • Breast-feeding and/or pregnant females
  • Male patients who are planning to father children during the trial period
  • Unable to comply with follow up protocol (for instance, limited life expectancy)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Singapore General Hospital

Singapore, 168609, Singapore

Location

Related Publications (1)

  • Wu CC, Lin MC, Pu SY, Tsai KC, Wen SC. Comparison of cutting balloon versus high-pressure balloon angioplasty for resistant venous stenoses of native hemodialysis fistulas. J Vasc Interv Radiol. 2008 Jun;19(6):877-83. doi: 10.1016/j.jvir.2008.02.016. Epub 2008 May 2.

    PMID: 18503902BACKGROUND

MeSH Terms

Conditions

Arteriovenous FistulaConstriction, Pathologic

Interventions

Angioplasty

Condition Hierarchy (Ancestors)

Arteriovenous MalformationsVascular MalformationsCardiovascular AbnormalitiesCardiovascular DiseasesVascular FistulaVascular DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesFistulaPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

CatheterizationTherapeuticsEndovascular ProceduresVascular Surgical ProceduresCardiovascular Surgical ProceduresSurgical Procedures, OperativeMinimally Invasive Surgical ProceduresInvestigative Techniques

Study Officials

  • Kun Da Zhuang, MBBS

    Singapore General Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 1
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 17, 2023

First Posted

July 27, 2023

Study Start

August 15, 2018

Primary Completion

June 30, 2019

Study Completion

June 30, 2019

Last Updated

July 27, 2023

Record last verified: 2023-07

Locations